Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Josephine Ocran"'
Autor:
Kwadwo A Koram, Bright Adu, Josephine Ocran, Yaa S Karikari, Susan Adu-Amankwah, Michael Ntiri, Benjamin Abuaku, Daniel Dodoo, Ben Gyan, Karl C Kronmann, Francis Nkrumah
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0163066 (2016)
The erythrocyte binding antigen region II (EBA-175 RII) is a Plasmodium falciparum ligand that mediates erythrocyte invasion and is considered an important malaria vaccine candidate. A phase Ia trial in malaria naïve adults living in the United Stat
Externí odkaz:
https://doaj.org/article/6b569de691644d239a854f54366ad871
Autor:
David K Dosoo, Kingsley Kayan, Dennis Adu-Gyasi, Evans Kwara, Josephine Ocran, Kingsley Osei-Kwakye, Emmanuel Mahama, Stephen Amenga-Etego, Philip Bilson, Kwaku P Asante, Kwadwo A Koram, Seth Owusu-Agyei
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e36308 (2012)
Reference values are very important in clinical management of patients, screening participants for enrollment into clinical trials and for monitoring the onset of adverse events during these trials. The aim of this was to establish gender-specific ha
Externí odkaz:
https://doaj.org/article/8e317654bb724e3f8ee63e03587f5171
Autor:
Dominicus Rolf, Ferrera Giuseppe, Freire Antônio Tarcísio, Lachance Pierre, Patrick Janice, Céline Boutry, Rodríguez de la Pinta Maria Luisa, Schaefer Axel, Hui David Shu Cheong, Schmidt Juergen, Plassmann Georg, Looze de Ferdinandus, Schenkenberger Isabelle, Josephine Ocran-Appiah, Toursarkissian Nicole, Grosskopf Josef, Beytout Jean, Staniscia Tommaso, Zahharova Irina, Klaff Leslie, Wachter Juergen, Kim Hyo Youl, Mueller Michael, Eto Takashi, Barbanti Piero, Lipetz Robert, Virta Miia, Ahonen Anitta, Ogata Hiroaki, Pauksens Karlis, McNally Damien, Grigat Christine, Geller Steven, Bengtsson Niklas, Poder Airi, Wilson Jonathan, Houser Patricia, Hwang Shinn-Jang, Berglund Johan Sanmartin, Jung Thomas, Rombo Lars, Datta Susan, Chlibeck Roman, Schubert Christian, Athan Eugene, Desole Maria Giuseppina, Huong Yieng, Dionne Marc, Stockhausen Juergen, Houle Pierre-Alain, Yunes Elsa Maria, Anne Schuind, Eckermann Tamara, Sueki Hirohiko, Schwarz Tino, Núñez López Concepción, Åke Olsson, Yeo Wilfred, Powell Calvin, Hartley Paul, Gerlach Beatrice, Curiac Dan, Hoeltz-Roehrig Susanne, Suzuki Shin, Mascareñas de Los Santos Abiel, Finneran Matthew, Ellison William, Narejos Pérez Silvia, Caroline Hervé, Pérez Vera Mercè, Powell Stephanie, Berndtsson Blom Katarina, Irimajiri Junya, Aldea Novo Marta, Dahmen Antje, Jacob Wilson, Kuroki Rie, Eizenberg Peter, Seppa Ilkka, Goldani Luciano, McNeil Shelly, Scott John, Liu Bo, Downey Herman Jackson, Andrews Charles, Caso Covadonga, Cunningham Anthony L, Toma Azhar, Lee Jacob, Ferguson Murdo, Weckx Lily, Berger-Roscher Juergen, Sauter Joachim, Park Dae Won, Forsten Aino, Barba-Gómez Jose-Fernando, Migliorino Guglielmo, Horacek Thomas, Levin Michael, Rosen Robert, Brotons Cuixart Carles, Koskinen Pekka, Schmitt Bernhard, Linnhoff Anneliese, Koenig Hans-Joachim, Tinoco Juan Carlos, Ghesquiere Wayne, Song Young Goo, Gauthier Jean-Sebastien, Icardi Giancarlo, Kokko Satu, Sha Edmund Kwok Yiu, Nakamura Kenjiro, Diez-Domingo Javier, Choo Eun-Ju, Lundvall Martin, Munir Abul Kashem, Jyoti Soni, Esen Meral, Arya Mark, Moeckesch Beate, Heaton Ken, Malempati Srikanth, Ervin John, Naritomi Yuji, Gorfinkel Iris, Manning Mary Beth, Tellier Guy, Poling Terry, Lee Jin-Soo
Publikováno v:
Vaccine. 39(1)
Background Efficacy of the adjuvanted recombinant zoster vaccine (RZV) against herpes zoster (HZ) was demonstrated in pivotal trials ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229). This study was designed to offer RZV to placebo recipients of these pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70e06a6d48e23064a25f46f9a3b63c11
https://pubmed.ncbi.nlm.nih.gov/33277059
https://pubmed.ncbi.nlm.nih.gov/33277059
Autor:
Chih-Ying Pratt, Judy A. Staffa, David Tyler Coyle, Josephine Ocran-Appiah, Cynthia Kornegay, Alex Secora
Publikováno v:
Pharmacoepidemiology and Drug Safety. 27:464-472
PURPOSE: Despite the rise in serious adverse events paralleling increased prescription opioid analgesic use in the United States over the past 2 decades, the association between opioid analgesic dose and the risk of serious adverse health outcomes is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2558680185f2c32e39d4820b469ffc0
https://doi.org/10.1002/pds.4366
https://doi.org/10.1002/pds.4366
Autor:
Catherine S. Hwang, Cynthia Kornegay, Yulan Ding, Josephine Ocran-Appiah, Judy A. Staffa, Elizabeth M. Kang, Jana K. McAninch, Tamra Meyer
Publikováno v:
JAMA Network Open
Key Points Question What percentage of patients receiving long-term immediate-release (IR) opioid analgesic therapy in the United States adds or switches to an extended-release/long-acting (ER/LA) formulation? Findings In this cohort study, most pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c5971a6a716964e66c6059e9f32328b
https://doi.org/10.1001/jamanetworkopen.2018.0216
https://doi.org/10.1001/jamanetworkopen.2018.0216
Autor:
Emmanuel Mahama, Seth Owusu-Agyei, Kingsley Osei-Kwakye, David Dosoo, Josephine Ocran, Philip Bilson, Evans Kwara, Dennis Adu-Gyasi, Kingsley Kayan, Stephen Amenga-Etego, Kwadwo A. Koram, Kwaku Poku Asante
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 4, p e36308 (2012)
PLoS ONE, Vol 7, Iss 4, p e36308 (2012)
BACKGROUND: Reference values are very important in clinical management of patients, screening participants for enrollment into clinical trials and for monitoring the onset of adverse events during these trials. The aim of this was to establish gender
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ee690dd99c95519a7ff40b50b6fca63
https://researchonline.lshtm.ac.uk/id/eprint/1319760/1/pone.0036308.pdf
https://researchonline.lshtm.ac.uk/id/eprint/1319760/1/pone.0036308.pdf
